OCTOPUS SECOND AIM VCT PLC (the 'Company')
7 January 2011
Issue of Equity
Octopus Second AIM VCT plc announces that 406,135 Ordinary Shares of £0.0001
each were issued and allotted to 19 subscribers at a price of 0.7439 pence per
share for cash by a Board Resolution passed on 7 January 2011. These shares have
been allotted in connection with the offer for subscription announced by the
Company on 9 July 2010.
Application has been made to the London Stock Exchange for admission of the new
shares. Admission is expected to become effective on or around 12 January 2011.
The issued share capital and total voting rights of the Company is now
37,022,445 Ordinary Shares.
For further information please contact:
Celia Whitten
Company Secretary
020 7710 2849
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Octopus Second AIM VCT plc via Thomson Reuters ONE
[HUG#1478102]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.